Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K.

Infect Immun. 2008 May;76(5):2240-8. doi: 10.1128/IAI.01585-07. Epub 2008 Mar 3.

2.

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Fowkes FJ, Richards JS, Simpson JA, Beeson JG.

PLoS Med. 2010 Jan 19;7(1):e1000218. doi: 10.1371/journal.pmed.1000218. Review.

3.

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.

Ibison F, Olotu A, Muema DM, Mwacharo J, Ohuma E, Kimani D, Marsh K, Bejon P, Ndungu FM.

PLoS One. 2012;7(12):e52939. doi: 10.1371/journal.pone.0052939. Epub 2012 Dec 26.

4.

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.

Rono J, Osier FH, Olsson D, Montgomery S, Mhoja L, Rooth I, Marsh K, Färnert A.

Clin Infect Dis. 2013 Nov;57(10):1409-16. doi: 10.1093/cid/cit556. Epub 2013 Aug 27.

5.

Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.

Dent AE, Nakajima R, Liang L, Baum E, Moormann AM, Sumba PO, Vulule J, Babineau D, Randall A, Davies DH, Felgner PL, Kazura JW.

J Infect Dis. 2015 Nov 1;212(9):1429-38. doi: 10.1093/infdis/jiv224. Epub 2015 Apr 15. Erratum in: J Infect Dis. 2016 Jan 1;213(1):167.

6.

High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.

Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, Berenzon SK, Wahlgren M, Linse S, Persson KE.

PLoS One. 2012;7(2):e32242. doi: 10.1371/journal.pone.0032242. Epub 2012 Feb 21.

7.

Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.

Akpogheneta OJ, Dunyo S, Pinder M, Conway DJ.

Parasite Immunol. 2010 Apr;32(4):296-304. doi: 10.1111/j.1365-3024.2009.01193.x.

8.

Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.

McCarra MB, Ayodo G, Sumba PO, Kazura JW, Moormann AM, Narum DL, John CC.

Pediatr Infect Dis J. 2011 Dec;30(12):1037-42. doi: 10.1097/INF.0b013e31822d1451.

9.
10.

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.

Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.

11.

Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.

Dobaño C, Quelhas D, Quintó L, Puyol L, Serra-Casas E, Mayor A, Nhampossa T, Macete E, Aide P, Mandomando I, Sanz S, Puniya SK, Singh B, Gupta P, Bhattacharya A, Chauhan VS, Aponte JJ, Chitnis CE, Alonso PL, Menéndez C.

Clin Vaccine Immunol. 2012 Feb;19(2):157-66. doi: 10.1128/CVI.05523-11. Epub 2011 Dec 14.

12.

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.

Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, Marsh K, Osier FH.

Vaccine. 2013 Aug 20;31(37):3936-42. doi: 10.1016/j.vaccine.2013.06.042. Epub 2013 Jun 22.

13.

Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.

Kangoye DT, Mensah VA, Murungi LM, Nkumama I, Nebie I, Marsh K, Cisse B, Bejon P, Osier FH, Sirima SB; MVVC Infant Immunology Study Group.

Vaccine. 2016 Jan 2;34(1):160-6. doi: 10.1016/j.vaccine.2015.10.058. Epub 2015 Nov 11.

14.

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.

Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K.

Vaccine. 2006 May 8;24(19):4233-46. Epub 2005 Jul 27.

PMID:
16111789
15.

Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.

Iriemenam NC, Khirelsied AH, Nasr A, ElGhazali G, Giha HA, Elhassan A-Elgadir TM, Agab-Aldour AA, Montgomery SM, Anders RF, Theisen M, Troye-Blomberg M, Elbashir MI, Berzins K.

Vaccine. 2009 Jan 1;27(1):62-71. doi: 10.1016/j.vaccine.2008.10.025. Epub 2008 Oct 31.

PMID:
18977268
16.

Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.

Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.

Infect Immun. 2006 May;74(5):2887-93.

18.

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper SJ, Osier FH.

Infect Immun. 2016 Mar 24;84(4):950-63. doi: 10.1128/IAI.01120-15. Print 2016 Apr.

19.

Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.

Pandey AK, Reddy KS, Sahar T, Gupta S, Singh H, Reddy EJ, Asad M, Siddiqui FA, Gupta P, Singh B, More KR, Mohmmed A, Chitnis CE, Chauhan VS, Gaur D.

Infect Immun. 2013 Feb;81(2):441-51. doi: 10.1128/IAI.01107-12. Epub 2012 Nov 26.

20.

Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

Cortés A, Mellombo M, Masciantonio R, Murphy VJ, Reeder JC, Anders RF.

Infect Immun. 2005 Jan;73(1):422-30.

Supplemental Content

Support Center